US EditionTrump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiative
Regeneron will sell Praluent for $225 through TrumpRx and offer its new gene therapy free to U.S. patients, the White House said.
- Donald Trump announced a deal with Regeneron to lower drug prices under a White House initiative.
- The agreement includes reduced prices on current and future drugs for Medicaid and discounted sales of Praluent.
- The move is part of broader efforts to address rising healthcare costs ahead of upcoming elections.
16 Articles
16 Articles
Donald Trump managed to get 17 pharmaceutical companies to agree to lower the price of their medicines, the most recent of which was Regeneron Pharmaceuticals.
Regeneron Strikes Drug Pricing Deal With Trump, Will Offer New Hearing-Loss Therapy for Free - The Thinking Conservative News
Regeneron Pharmaceuticals became the latest drug manufacturer to enter a Most Favored Nation drug pricing agreement with the United States. The post Regeneron Strikes Drug Pricing Deal With Trump, Will Offer New Hearing-Loss Therapy for Free appeared first on The Thinking Conservative News.
Regeneron Strikes Drug Pricing Deal With Trump, Will Offer New Hearing-Loss Therapy for Free
Regeneron Pharmaceuticals on April 23 became the latest drug manufacturer to enter a Most Favored Nation drug pricing agreement with the United States. President Donald Trump announced the deal from the Oval Office. “With this announcement, 17 of the world’s largest pharmaceutical companies, representing 80 percent of the branded drug market, have now agreed to sell their drugs to American patients at the lowest prices anywhere in the world,” Tr…
Coverage Details
Bias Distribution
- 58% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
